Kardigan Inc. (KARD:NASDAQ) closed at $12.85 on October 21, 2026, down 4.89% on the day. The stock trades 52.4% below its 52-week high of $27.00 and 5.1% above its 52-week low of $12.23. Over the past year, it lost 41.6%. Kardigan Inc. is part of the Health Care sector.
In 86 trading sessions since June 22, 2026, KARD closed higher on 43 days (50%). Its best day was September 2, 2026 (+11.84%) and its worst was September 23, 2026 (-11.68%). The stock moved 10% or more in a single session 4 times.
Kardigan is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. Led by a proven and experienced management team, Kardigan is reimagining cardiovascular drug discovery and development through an integrated approach that unites deep cardiovascular biology, real-world patient data, and advanced analytics to enable more precise, efficient, and informed development of novel therapies. The company is based in South San Francisco, California and Princeton, New Jersey.
Find more stocks like KARD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.